![YPK YPK](https://data.pdbj.org/pdbjplus/data/cc/svg/YPK.svg) | YPK | Name: | [(3S)-1-[4-(dimethylamino)butanoyl]pyrrolidin-3-yl] 4-[(5-methyl-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate | Formula: | C26 H41 N7 O3 | SMILES: | CC(C)c1cnn2c(NC3CCN(CC3)C(=O)O[CH]4CCN(C4)C(=O)CCCN(C)C)cc(C)nc12 | InChi: | InChI=1S/C26H41N7O3/c1-18(2)22-16-27-33-23(15-19(3)28-25(22)33)29-20-8-12-31(13-9-20)26(35)36-21-10-14-32(17-21)24(34)7-6-11-30(4)5/h15-16,18,20-21,29H,6-14,17H2,1-5H3/t21-/m0/s1 | Synonyms: | HYDROXYETHYLAMINE BACE INHIBITOR | Definition date: | 2023-12-08 | Last modified: | 2024-05-24 | Release date: | 2024-05-29 | Identifier: | [(3~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-3-yl] 4-[(5-methyl-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate |
|
![A1AQI A1AQI](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AQI.svg) | A1AQI | Name: | 1-(propan-2-yl)-1H-1,3-benzimidazol-2-amine | Formula: | C10 H13 N3 | SMILES: | CC(C)n1c2ccccc2nc1N | InChi: | InChI=1S/C10H13N3/c1-7(2)13-9-6-4-3-5-8(9)12-10(13)11/h3-7H,1-2H3,(H2,11,12) | Definition date: | 2024-04-29 | Last modified: | 2024-05-24 | Release date: | 2024-05-29 | Identifier: | 1-(propan-2-yl)-1H-1,3-benzimidazol-2-amine |
|
![A1ASB A1ASB](https://data.pdbj.org/pdbjplus/data/cc/svg/A1ASB.svg) | A1ASB | Name: | (1Z)-N-hydroxy-2-methylpropanimidamide | Formula: | C4 H10 N2 O | SMILES: | CC(C)C(=N)NO | InChi: | InChI=1S/C4H10N2O/c1-3(2)4(5)6-7/h3,7H,1-2H3,(H2,5,6) | Definition date: | 2024-05-15 | Last modified: | 2024-05-24 | Release date: | 2024-05-29 | Identifier: | (1Z)-N-hydroxy-2-methylpropanimidamide |
|
![A1H1J A1H1J](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H1J.svg) | A1H1J | Name: | (phenylmethyl) ~{N}-[(2~{S})-1-[[(3-chloranyl-2-fluoranyl-phenyl)methyl-(iminomethyl)amino]-methyl-amino]-1-oxidanylidene-3-phenyl-propan-2-yl]carbamate | Formula: | C26 H26 Cl F N4 O3 | SMILES: | CN(N(Cc1cccc(Cl)c1F)C=N)C(=O)[CH](Cc2ccccc2)NC(=O)OCc3ccccc3 | InChi: | InChI=1S/C26H26ClFN4O3/c1-31(32(18-29)16-21-13-8-14-22(27)24(21)28)25(33)23(15-19-9-4-2-5-10-19)30-26(34)35-17-20-11-6-3-7-12-20/h2-14,18,23,29H,15-17H2,1H3,(H,30,34)/b29-18-/t23-/m0/s1 | Definition date: | 2023-12-22 | Last modified: | 2024-05-24 | Release date: | 2024-05-29 | Identifier: | (phenylmethyl) ~{N}-[(2~{S})-1-[[(3-chloranyl-2-fluoranyl-phenyl)methyl-(iminomethyl)amino]-methyl-amino]-1-oxidanylidene-3-phenyl-propan-2-yl]carbamate |
|
![X5C X5C](https://data.pdbj.org/pdbjplus/data/cc/svg/X5C.svg) | X5C | Name: | N-[(2S)-1-[[(2S)-1-[[(1S)-1-[(2S,3R,5S,6R)-3-(hydroxymethyl)-5-methanoyl-2,3,6-trimethyl-morpholin-2-yl]-2-phenyl-ethyl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]hexanamide | Formula: | C45 H56 N6 O6 | SMILES: | CCCCCC(=O)N[CH](Cc1c[nH]c2ccccc12)C(=O)N[CH](Cc3c[nH]c4ccccc34)C(=O)N[CH](Cc5ccccc5)[C]6(C)O[CH](C)[CH](N[C]6(C)CO)C=O | InChi: | InChI=1S/C45H56N6O6/c1-5-6-8-21-41(54)48-37(23-31-25-46-35-19-13-11-17-33(31)35)42(55)49-38(24-32-26-47-36-20-14-12-18-34(32)36)43(56)50-40(22-30-15-9-7-10-16-30)45(4)44(3,28-53)51-39(27-52)29(2)57-45/h7,9-20,25-27,29,37-40,46-47,51,53H,5-6,8,21-24,28H2,1-4H3,(H,48,54)(H,49,55)(H,50,56)/t29-,37+,38+,39-,40+,44-,45+/m1/s1 | Synonyms: | proteasome inhibitor CP-17 | Definition date: | 2023-05-31 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | ~{N}-[(2~{S})-1-[[(2~{S})-1-[[(1~{S})-1-[(2~{S},3~{R},5~{S},6~{R})-3-(hydroxymethyl)-5-methanoyl-2,3,6-trimethyl-morpholin-2-yl]-2-phenyl-ethyl]amino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]hexanamide |
|
![A1H4A A1H4A](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H4A.svg) | A1H4A | Name: | 8-[4-methyl-3-(trifluoromethyl)phenyl]-2-[[(7S)-7-(2-morpholin-4-ylethylcarbamoyl)-4-(phenylsulfonyl)-1,4-diazepan-1-yl]carbonyl]imidazo[1,2-a]pyridine-6-carboxylic acid | Formula: | C35 H37 F3 N6 O7 S | SMILES: | Cc1ccc(cc1C(F)(F)F)c2cc(cn3cc(nc23)C(=O)N4CCN(CC[CH]4C(=O)NCCN5CCOCC5)[S](=O)(=O)c6ccccc6)C(O)=O | InChi: | InChI=1S/C35H37F3N6O7S/c1-23-7-8-24(20-28(23)35(36,37)38)27-19-25(34(47)48)21-42-22-29(40-31(27)42)33(46)44-14-13-43(52(49,50)26-5-3-2-4-6-26)11-9-30(44)32(45)39-10-12-41-15-17-51-18-16-41/h2-8,19-22,30H,9-18H2,1H3,(H,39,45)(H,47,48)/t30-/m0/s1 | Synonyms: | LIPID FRAGMENT | Definition date: | 2024-02-13 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | 8-[4-methyl-3-(trifluoromethyl)phenyl]-2-[[(7~{S})-7-(2-morpholin-4-ylethylcarbamoyl)-4-(phenylsulfonyl)-1,4-diazepan-1-yl]carbonyl]imidazo[1,2-a]pyridine-6-carboxylic acid |
|
![A1LVB A1LVB](https://data.pdbj.org/pdbjplus/data/cc/svg/A1LVB.svg) | A1LVB | Name: | (2~{R},3~{S})-3-[[(2~{S})-2-(4-chlorophenyl)-2-fluoranyl-ethanoyl]amino]-3-[3-(2-cyano-2-methyl-propoxy)-4-methyl-phenyl]-2-methyl-propanoic acid | Formula: | C24 H26 Cl F N2 O4 | SMILES: | C[CH]([CH](NC(=O)[CH](F)c1ccc(Cl)cc1)c2ccc(C)c(OCC(C)(C)C#N)c2)C(O)=O | InChi: | InChI=1S/C24H26ClFN2O4/c1-14-5-6-17(11-19(14)32-13-24(3,4)12-27)21(15(2)23(30)31)28-22(29)20(26)16-7-9-18(25)10-8-16/h5-11,15,20-21H,13H2,1-4H3,(H,28,29)(H,30,31) | Definition date: | 2023-12-19 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | (2~{R},3~{S})-3-[[(2~{S})-2-(4-chlorophenyl)-2-fluoranyl-ethanoyl]amino]-3-[3-(2-cyano-2-methyl-propoxy)-4-methyl-phenyl]-2-methyl-propanoic acid |
|
![A1LVC A1LVC](https://data.pdbj.org/pdbjplus/data/cc/svg/A1LVC.svg) | A1LVC | Name: | (2~{R},3~{S})-3-[[(2~{S})-2-[4-[(3-ethoxypyridin-2-yl)methyl]phenyl]-2-fluoranyl-ethanoyl]amino]-2-methyl-3-(4-methylphenyl)propanoic acid | Formula: | C27 H29 F N2 O4 | SMILES: | CCOc1cccnc1Cc2ccc(cc2)[CH](F)C(=O)N[CH]([CH](C)C(O)=O)c3ccc(C)cc3 | InChi: | InChI=1S/C27H29FN2O4/c1-4-34-23-6-5-15-29-22(23)16-19-9-13-20(14-10-19)24(28)26(31)30-25(18(3)27(32)33)21-11-7-17(2)8-12-21/h5-15,18,24-25H,4,16H2,1-3H3,(H,30,31)(H,32,33) | Definition date: | 2023-12-19 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | (2~{R},3~{S})-3-[[(2~{S})-2-[4-[(3-ethoxypyridin-2-yl)methyl]phenyl]-2-fluoranyl-ethanoyl]amino]-2-methyl-3-(4-methylphenyl)propanoic acid |
|
![A1LZU A1LZU](https://data.pdbj.org/pdbjplus/data/cc/svg/A1LZU.svg) | A1LZU | Name: | [2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate | Formula: | C13 H21 O5 P | SMILES: | CC(C)c1cccc(C(C)C)c1OCO[P](O)(O)=O | InChi: | InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) | Definition date: | 2024-03-29 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | [2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate |
|
![30Y 30Y](https://data.pdbj.org/pdbjplus/data/cc/svg/30Y.svg) | 30Y | Name: | (2R)-3-[(2-chlorophenyl)amino]-2-cyano-3-thioxo-N-[3-(trifluoromethyl)phenyl]propanamide | Formula: | C17 H11 Cl F3 N3 O S | SMILES: | Clc2ccccc2NC(=S)C(C#N)C(=O)Nc1cc(ccc1)C(F)(F)F | InChi: | InChI=1S/C17H11ClF3N3OS/c18-13-6-1-2-7-14(13)24-16(26)12(9-22)15(25)23-11-5-3-4-10(8-11)17(19,20)21/h1-8,12H,(H,23,25)(H,24,26)/t12-/m1/s1 | Definition date: | 2014-05-16 | Last modified: | 2024-05-17 | Release date: | 2024-05-22 | Identifier: | (2R)-3-[(2-chlorophenyl)amino]-2-cyano-3-thioxo-N-[3-(trifluoromethyl)phenyl]propanamide |
|
![YDL YDL](https://data.pdbj.org/pdbjplus/data/cc/svg/YDL.svg) | YDL | Name: | N-(methoxycarbonyl)-3-methyl-L-valyl-(4R)-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-(trifluoromethyl)-L-prolinamide | Formula: | C21 H32 F3 N5 O5 | SMILES: | FC(F)(F)C1CC(C(=O)NC(C=N)CC2CCNC2=O)N(C1)C(=O)C(NC(=O)OC)C(C)(C)C | InChi: | InChI=1S/C21H32F3N5O5/c1-20(2,3)15(28-19(33)34-4)18(32)29-10-12(21(22,23)24)8-14(29)17(31)27-13(9-25)7-11-5-6-26-16(11)30/h9,11-15,25H,5-8,10H2,1-4H3,(H,26,30)(H,27,31)(H,28,33)/t11-,12+,13-,14-,15+/m0/s1 | Synonyms: | Ibuzatrelvir, bound form | Definition date: | 2023-12-01 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | N-(methoxycarbonyl)-3-methyl-L-valyl-(4R)-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-(trifluoromethyl)-L-prolinamide |
|
![Y5I Y5I](https://data.pdbj.org/pdbjplus/data/cc/svg/Y5I.svg) | Y5I | Name: | 3-[2-fluoranyl-4-[3-[2-fluoranyl-4-(5-methyl-1,3,4-thiadiazol-2-yl)phenoxy]propoxy]phenyl]propanoic acid | Formula: | C21 H20 F2 N2 O4 S | SMILES: | Cc1sc(nn1)c2ccc(OCCCOc3ccc(CCC(O)=O)c(F)c3)c(F)c2 | InChi: | InChI=1S/C21H20F2N2O4S/c1-13-24-25-21(30-13)15-4-7-19(18(23)11-15)29-10-2-9-28-16-6-3-14(17(22)12-16)5-8-20(26)27/h3-4,6-7,11-12H,2,5,8-10H2,1H3,(H,26,27) | Definition date: | 2023-06-12 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | 3-[2-fluoranyl-4-[3-[2-fluoranyl-4-(5-methyl-1,3,4-thiadiazol-2-yl)phenoxy]propoxy]phenyl]propanoic acid |
|
![A1AI9 A1AI9](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AI9.svg) | A1AI9 | Name: | (3R)-3-[4-(cyclopropylcarbamamido)benzamido]-3-[3-(difluoromethyl)phenyl]propanoic acid | Formula: | C21 H21 F2 N3 O4 | SMILES: | O=C(Nc1ccc(cc1)C(=O)NC(CC(=O)O)c1cccc(c1)C(F)F)NC1CC1 | InChi: | InChI=1S/C21H21F2N3O4/c22-19(23)14-3-1-2-13(10-14)17(11-18(27)28)26-20(29)12-4-6-15(7-5-12)24-21(30)25-16-8-9-16/h1-7,10,16-17,19H,8-9,11H2,(H,26,29)(H,27,28)(H2,24,25,30)/t17-/m1/s1 | Definition date: | 2024-04-01 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (3R)-3-[4-(cyclopropylcarbamamido)benzamido]-3-[3-(difluoromethyl)phenyl]propanoic acid |
|
![1XR 1XR](https://data.pdbj.org/pdbjplus/data/cc/svg/1XR.svg) | 1XR | Name: | Bupropion | Formula: | C13 H18 Cl N O | SMILES: | C[CH](NC(C)(C)C)C(=O)c1cccc(Cl)c1 | InChi: | InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m0/s1 | Synonyms: | Amfebutamone | Definition date: | 2022-11-17 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (2~{S})-2-(~{tert}-butylamino)-1-(3-chlorophenyl)propan-1-one |
|
![A1AKF A1AKF](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AKF.svg) | A1AKF | Name: | (3R)-3-(4-fluorophenyl)-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid | Formula: | C16 H13 F N4 O3 | SMILES: | Fc1ccc(cc1)C(CC(=O)O)NC(=O)c1ncnc2[NH]ccc12 | InChi: | InChI=1S/C16H13FN4O3/c17-10-3-1-9(2-4-10)12(7-13(22)23)21-16(24)14-11-5-6-18-15(11)20-8-19-14/h1-6,8,12H,7H2,(H,21,24)(H,22,23)(H,18,19,20)/t12-/m1/s1 | Definition date: | 2024-04-03 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (3R)-3-(4-fluorophenyl)-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid |
|
![A1AKQ A1AKQ](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AKQ.svg) | A1AKQ | Name: | (3R)-3-(4-bromophenyl)-3-[(1H-pyrrolo[2,3-b]pyridine-5-carbonyl)amino]propanoic acid | Formula: | C17 H14 Br N3 O3 | SMILES: | Brc1ccc(cc1)C(CC(=O)O)NC(=O)c1cc2cc[NH]c2nc1 | InChi: | InChI=1S/C17H14BrN3O3/c18-13-3-1-10(2-4-13)14(8-15(22)23)21-17(24)12-7-11-5-6-19-16(11)20-9-12/h1-7,9,14H,8H2,(H,19,20)(H,21,24)(H,22,23)/t14-/m1/s1 | Definition date: | 2024-04-04 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (3R)-3-(4-bromophenyl)-3-[(1H-pyrrolo[2,3-b]pyridine-5-carbonyl)amino]propanoic acid |
|
![A1AKV A1AKV](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AKV.svg) | A1AKV | Name: | 3-cyclopropyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-L-alanine | Formula: | C12 H14 N4 O2 | SMILES: | O=C(O)C(CC1CC1)Nc1ncnc2[NH]ccc21 | InChi: | InChI=1S/C12H14N4O2/c17-12(18)9(5-7-1-2-7)16-11-8-3-4-13-10(8)14-6-15-11/h3-4,6-7,9H,1-2,5H2,(H,17,18)(H2,13,14,15,16) | Definition date: | 2024-04-04 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | 3-cyclopropyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-L-alanine |
|
![A1AKZ A1AKZ](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AKZ.svg) | A1AKZ | Name: | (3S)-3-[3-(methanesulfonamido)phenyl]-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid | Formula: | C17 H17 N5 O5 S | SMILES: | CS(=O)(=O)Nc1cccc(c1)C(CC(=O)O)NC(=O)c1ncnc2[NH]ccc12 | InChi: | InChI=1S/C17H17N5O5S/c1-28(26,27)22-11-4-2-3-10(7-11)13(8-14(23)24)21-17(25)15-12-5-6-18-16(12)20-9-19-15/h2-7,9,13,22H,8H2,1H3,(H,21,25)(H,23,24)(H,18,19,20)/t13-/m0/s1 | Definition date: | 2024-04-05 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (3S)-3-[3-(methanesulfonamido)phenyl]-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid |
|
![A1AMU A1AMU](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AMU.svg) | A1AMU | Name: | (2S,3S)-3-(4-bromophenyl)-2-methyl-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid | Formula: | C17 H15 Br N4 O3 | SMILES: | O=C(O)C(C)C(NC(=O)c1ncnc2[NH]ccc12)c1ccc(Br)cc1 | InChi: | InChI=1S/C17H15BrN4O3/c1-9(17(24)25)13(10-2-4-11(18)5-3-10)22-16(23)14-12-6-7-19-15(12)21-8-20-14/h2-9,13H,1H3,(H,22,23)(H,24,25)(H,19,20,21)/t9-,13-/m0/s1 | Definition date: | 2024-04-15 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (2S,3S)-3-(4-bromophenyl)-2-methyl-3-[(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]propanoic acid |
|
![AJF AJF](https://data.pdbj.org/pdbjplus/data/cc/svg/AJF.svg) | AJF | Name: | methyl (2S)-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate | Formula: | C19 H19 N O4 | SMILES: | COC(=O)[CH](Cc1ccccc1)NC(=O)c2cccc(c2)C(C)=O | InChi: | InChI=1S/C19H19NO4/c1-13(21)15-9-6-10-16(12-15)18(22)20-17(19(23)24-2)11-14-7-4-3-5-8-14/h3-10,12,17H,11H2,1-2H3,(H,20,22)/t17-/m0/s1 | Definition date: | 2023-05-16 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | methyl (2~{S})-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate |
|
![KW0 KW0](https://data.pdbj.org/pdbjplus/data/cc/svg/KW0.svg) | KW0 | Name: | (2~{S})-2-azanyl-3-[[(2~{R})-1-ethoxy-3-[(~{Z})-octadec-9-enoyl]oxy-propan-2-yl]oxy-oxidanyl-phosphoryl]oxy-propanoic acid | Formula: | C26 H50 N O9 P | SMILES: | CCCCCCCCC=CCCCCCCCC(=O)OC[CH](COCC)O[P](O)(=O)OC[CH](N)C(O)=O | InChi: | InChI=1S/C26H50NO9P/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)34-21-23(20-33-4-2)36-37(31,32)35-22-24(27)26(29)30/h11-12,23-24H,3-10,13-22,27H2,1-2H3,(H,29,30)(H,31,32)/b12-11-/t23-,24+/m1/s1 | Definition date: | 2022-10-20 | Last modified: | 2024-05-10 | Release date: | 2024-05-15 | Identifier: | (2~{S})-2-azanyl-3-[[(2~{R})-1-ethoxy-3-[(~{Z})-octadec-9-enoyl]oxy-propan-2-yl]oxy-oxidanyl-phosphoryl]oxy-propanoic acid |
|
![9OR 9OR](https://data.pdbj.org/pdbjplus/data/cc/svg/9OR.svg) | 9OR | Name: | 3-[7,8-dimethyl-2,4-bis(oxidanylidene)-10-[(2S,3S,4R)-2,3,4-tris(oxidanyl)-5-phosphonooxy-pentyl]-1H-benzo[g]pteridin-5-yl]-3-oxidanylidene-propanoic acid | Formula: | C20 H25 N4 O12 P | SMILES: | O=P(O)(O)OCC(O)C(O)C(O)CN1C=2NC(=O)NC(=O)C=2N(c2cc(C)c(C)cc21)C(=O)CC(=O)O | InChi: | InChI=1S/C20H25N4O12P/c1-8-3-10-11(4-9(8)2)24(14(27)5-15(28)29)16-18(21-20(32)22-19(16)31)23(10)6-12(25)17(30)13(26)7-36-37(33,34)35/h3-4,12-13,17,25-26,30H,5-7H2,1-2H3,(H,28,29)(H2,33,34,35)(H2,21,22,31,32)/t12-,13+,17-/m0/s1 | Definition date: | 2018-06-15 | Last modified: | 2024-05-08 | Release date: | 2019-06-19 | Identifier: | 1-[5-(carboxyacetyl)-7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl]-1-deoxy-5-O-phosphono-D-ribitol |
|
![EJA EJA](https://data.pdbj.org/pdbjplus/data/cc/svg/EJA.svg) | EJA | Name: | S-[(1Z)-2-carboxy-N-hydroxyethanimidoyl]-L-cysteine | Formula: | C6 H10 N2 O5 S | SMILES: | NC(CSC(=N/O)CC(O)=O)C(O)=O | InChi: | InChI=1S/C6H10N2O5S/c7-3(6(11)12)2-14-4(8-13)1-5(9)10/h3,13H,1-2,7H2,(H,9,10)(H,11,12)/b8-4-/t3-/m0/s1 | Definition date: | 2018-01-12 | Last modified: | 2024-05-08 | Release date: | 2018-06-06 | Identifier: | S-[(1Z)-2-carboxy-N-hydroxyethanimidoyl]-L-cysteine |
|
![8VV 8VV](https://data.pdbj.org/pdbjplus/data/cc/svg/8VV.svg) | 8VV | Name: | (1S)-2-{2-[(R)-(2R)-2-amino-2-carboxyethanesulfinyl]-1H-imidazol-4-yl}-1-carboxy-N,N,N-trimethylethan-1-aminium | Formula: | C12 H21 N4 O5 S | SMILES: | O=S(CC(N)C(=O)O)c1nc(CC(C(=O)O)[N+](C)(C)C)c[NH]1 | InChi: | InChI=1S/C12H20N4O5S/c1-16(2,3)9(11(19)20)4-7-5-14-12(15-7)22(21)6-8(13)10(17)18/h5,8-9H,4,6,13H2,1-3H3,(H2-,14,15,17,18,19,20)/p+1/t8-,9-,22+/m0/s1 | Definition date: | 2017-03-08 | Last modified: | 2024-05-08 | Release date: | 2018-03-07 | Identifier: | (1S)-2-{2-[(R)-(2R)-2-amino-2-carboxyethanesulfinyl]-1H-imidazol-4-yl}-1-carboxy-N,N,N-trimethylethan-1-aminium |
|
![1G1 1G1](https://data.pdbj.org/pdbjplus/data/cc/svg/1G1.svg) | 1G1 | Name: | N3Phe-Leu-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | Formula: | C33 H49 N7 O5 S | SMILES: | NCc1ccc(CC(CCS(C)(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)/N=[N+]=[N-])cc1 | InChi: | InChI=1S/C33H49N7O5S/c1-22(2)17-28(31(41)36-27(15-16-46(5,44)45)19-25-11-13-26(21-34)14-12-25)37-32(42)29(18-23(3)4)38-33(43)30(39-40-35)20-24-9-7-6-8-10-24/h6-14,22-23,27-30H,15-21,34H2,1-5H3,(H,36,41)(H,37,42)(H,38,43)/t27-,28+,29+,30+/m1/s1 | Definition date: | 2013-01-22 | Last modified: | 2024-05-08 | Release date: | 2013-01-25 | Identifier: | N-[(2S)-2-azido-3-phenylpropanoyl]-L-leucyl-N-[(2S)-1-[4-(aminomethyl)phenyl]-4-(methanesulfonyl)butan-2-yl]-L-leucinamide |
|